Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin

被引：14
|
作者：
Pérez-Guerrero, C [1 ]
Márquez-Martín, A [1 ]
Herrera, MD [1 ]
Marhuenda, E [1 ]
de Sotomayor, MA [1 ]
机构：
[1] Univ Seville, Fac Pharm, Dept Pharmacol, ES-41012 Seville, Spain
来源：
PHARMACOLOGY | 2005年 / 74卷 / 04期
关键词：
HMG-CoA reductase; simvastatin; calcium; Rho-kinase; spontaneously hypertensive rat;
D O I：
10.1159/000085957
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The acute effect of simvastatin on aortic rings from spontaneously hypertensive rats (SHRs) was identified. Simvastatin-evoked relaxations of both depolarized and phenylephrine-precontracted arteries were independent of the presence of endothelium. This effect was inhibited by diltiazem and mevalonate, but not by the Rho-kinase inhibitor, Y-27632. Simvastatin prevented contraction induced by phenylephrine, calcium ionophore A-23187 and CaCl2 in Ca2+- free medium. Y-27632 decreased the effect of simvastatin. On the contrary, contraction induced by noradrenaline in Ca2+- free medium was not affected. These results suggest that simvastatin elicited an effect on vascular smooth muscle cells from SHRs that may involve blockade of extracellular calcium entry and decrease vascular contraction by affecting Rho-kinase. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码：209 / 215
页数：7
相关论文
共 50 条
  • [41] In vitro and in vivo antiproliferative effects of simvastatin, an HMG-CoA reductase inhibitor, on human glioma cells
    Kikuchi, T
    Nagata, Y
    Abe, T
    JOURNAL OF NEURO-ONCOLOGY, 1997, 34 (03) : 233 - 239
  • [42] HMG-COA reductase inhibitor, simvastatin, enhances AKT protein levels in heart failure.
    Bates, K
    Johnson, N
    Wollmuth, J
    Goldman, S
    Gaballa, M
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S115 - S115
  • [43] HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation
    Skrzypiec-Spring, Monika
    Sapa-Wojciechowska, Agnieszka
    Haczkiewicz-Lesniak, Katarzyna
    Piasecki, Tomasz
    Kwiatkowska, Joanna
    Podhorska-Okolow, Marzenna
    Szelag, Adam
    BIOMOLECULES, 2021, 11 (10)
  • [44] SIMVASTATIN, A COMPETITIVE INHIBITOR OF HMG-COA REDUCTASE, LOWERS CHOLESTEROL SATURATION INDEX OF GALLBLADDER BILE
    DUANE, WC
    HUNNINGHAKE, DB
    FREEMAN, ML
    POOLER, PA
    SCHLASNER, LA
    GEBHARD, RL
    HEPATOLOGY, 1988, 8 (05) : 1147 - 1150
  • [45] Simvastatin, a HMG-CoA reductase inhibitor, in traumatic brain injury: effects on brain edema mechanisms
    Tiphaine, B.
    Chen, X.
    El Shafey, N.
    Frechou, M.
    Teng, F.
    Palmier, B.
    Beray-Berthat, V.
    Soustrat, M.
    Margaill, I.
    Plotkine, M.
    Marchand-Leroux, C.
    Besson, V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 66 - 67
  • [46] SIMVASTATIN, AN INHIBITOR OF HMG-COA REDUCTASE, LOWERS CHOLESTEROL SATURATION INDEX OF GALLBLADDER BILE IN MAN
    DUANE, WC
    GEBHARD, RL
    HUNNINGHAKE, DB
    POOLER, PA
    FREEMAN, ML
    GASTROENTEROLOGY, 1988, 94 (05) : A537 - A537
  • [47] In vitro and in vivo antiproliferative effects of simvastatin, an HMG-CoA reductase inhibitor, on human glioma cells
    Tetsuro Kikuchi
    Yasufumi Nagata
    Toshiaki Abe
    Journal of Neuro-Oncology, 1997, 34 : 233 - 239
  • [48] EFFECTS OF SIMVASTATIN, AN HMG-COA REDUCTASE INHIBITOR, ON PLASMA-LIPIDS AND STEROID-HORMONES
    IDE, H
    FUJIYA, S
    AANUMA, Y
    AGISHI, Y
    CLINICAL THERAPEUTICS, 1990, 12 (05) : 410 - 420
  • [49] HMG-CoA reductase inhibitor, fluvastatin, successfully improved endothelial function and reduced albuminuria in diabetic and hypertensive rats
    Tomita, N
    Yamasaki, K
    Izawa, K
    Kunugiza, Y
    Kioke, H
    Ogihara, T
    Morishita, R
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E41 - E41
  • [50] Cataract and HMG-CoA reductase inhibitor: a case report
    Bousquet, E
    Amar, J
    Salvador, M
    Chamontin, B
    THERAPIE, 1998, 53 (05): : 505 - 507
12345